Literature DB >> 18162519

The melanocortin 2 receptor accessory protein exists as a homodimer and is essential for the function of the melanocortin 2 receptor in the mouse y1 cell line.

Sadani N Cooray1, Isabel Almiro Do Vale, Kit-Yi Leung, Tom R Webb, J Paul Chapple, Michaela Egertová, Michael E Cheetham, Maurice R Elphick, Adrian J L Clark.   

Abstract

The ACTH receptor [melanocortin 2 receptor (MC2R)] gene produces a functional receptor only when transfected into cells of adrenocortical origin, implying that it may require an adrenal-specific accessory factor. Recently we showed that the MC2R accessory protein (MRAP) is essential for the cell surface expression of the MC2R in such models. Using RNA interference (RNAi) technology, we have further explored the action of MRAP in the functioning of the MC2R in Y1 mouse adrenocortical cells that endogenously express MRAP and MC2R. We created stable cell lines expressing mouse MRAP short hairpin RNA (shRNAs) by transfecting cells with an expression vector containing the MRAP small interfering RNA sequence. The knockdown of MRAP resulted in a reduction in MC2R signaling. The overexpression of a mouse MRAP-Flag construct did not restore the expression of MRAP due to its degradation by the mouse shRNAs. The introduction of human MRAP that is resistant to silencing by mouse MRAP shRNAs resulted in the rescue of the MC2R signaling. MRAP migrates on SDS-PAGE with markedly lower mobility than predicted for a 14.1-kDa protein. Coimmunoprecipitation and mass spectroscopy suggests that MRAP exists as a homodimer that is resistant to dissociation by sodium dodecyl sulfate and reducing agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18162519     DOI: 10.1210/en.2007-1463

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  30 in total

1.  Regulation of G protein-coupled receptor signaling: specific dominant-negative effects of melanocortin 2 receptor accessory protein 2.

Authors:  Julien A Sebag; Patricia M Hinkle
Journal:  Sci Signal       Date:  2010-04-06       Impact factor: 8.192

2.  The high-affinity cAMP-specific phosphodiesterase 8B controls steroidogenesis in the mouse adrenal gland.

Authors:  Li-Chun Lisa Tsai; Masami Shimizu-Albergine; Joseph A Beavo
Journal:  Mol Pharmacol       Date:  2010-12-27       Impact factor: 4.436

Review 3.  The year in G protein-coupled receptor research.

Authors:  Robert P Millar; Claire L Newton
Journal:  Mol Endocrinol       Date:  2009-12-17

Review 4.  Intracellular signaling mechanisms of the melanocortin receptors: current state of the art.

Authors:  Adriana R Rodrigues; Henrique Almeida; Alexandra M Gouveia
Journal:  Cell Mol Life Sci       Date:  2014-12-12       Impact factor: 9.261

5.  Trafficking of bluetongue virus visualized by recovery of tetracysteine-tagged virion particles.

Authors:  Junzheng Du; Bishnupriya Bhattacharya; Theresa H Ward; Polly Roy
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

6.  Estrogen Suppresses Interaction of Melanocortin 2 Receptor and Its Accessory Protein in the Primate Fetal Adrenal Cortex.

Authors:  Jeffery S Babischkin; Graham W Aberdeen; Gerald J Pepe; Eugene D Albrecht
Journal:  Endocrinology       Date:  2016-10-25       Impact factor: 4.736

7.  Regions of melanocortin 2 (MC2) receptor accessory protein necessary for dual topology and MC2 receptor trafficking and signaling.

Authors:  Julien A Sebag; Patricia M Hinkle
Journal:  J Biol Chem       Date:  2008-11-03       Impact factor: 5.157

Review 8.  Minireview: the melanocortin 2 receptor accessory proteins.

Authors:  Tom R Webb; Adrian J L Clark
Journal:  Mol Endocrinol       Date:  2009-10-23

Review 9.  The evolution and comparative neurobiology of endocannabinoid signalling.

Authors:  Maurice R Elphick
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

10.  Melanocortin 4 receptor becomes an ACTH receptor by coexpression of melanocortin receptor accessory protein 2.

Authors:  Maria Josep Agulleiro; Raúl Cortés; Begoña Fernández-Durán; Sandra Navarro; Raúl Guillot; Eirini Meimaridou; Adrian J L Clark; José Miguel Cerdá-Reverter
Journal:  Mol Endocrinol       Date:  2013-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.